ALERT: Khang & Khang LLP Announces an Investigation of Claims against HeartWare International Inc. & Strongly Encourages Inve...
October 29 2015 - 8:58PM
Business Wire
Khang & Khang LLP announces that it is investigating claims
of potential misrepresentations by HeartWare International Inc.
(“HeartWare” or the “Company”) (NASDAQ:HTWR). The investigation
focuses on whether the Company and its officers violated securities
laws by issuing misleading information to investors.
If you purchased shares of HeartWare during the Class Period,
please contact Joon M. Khang, Esquire, of Khang & Khang, 18101
Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949)
419-3834, or by e-mail at joon@khanglaw.com.
There has been no class certification in this case. Until
certification occurs, you are not represented by an attorney. You
may choose to take no action and remain a passive class member.
On September 9, 2015, HeartWare announced that it had stopped
its MVAD clinical trial to address an MVAD controller manufacturing
process problem. On October 13, 2015, HeartWare reported it might
not re-initiate enrollment in the MVAD clinical trial in November
as it had previously planned.
If you wish to learn more about this lawsuit, or if
you have any questions concerning this notice or your rights,
please contact Joon M. Khang, a prominent litigator for almost two
decades, by telephone: (949) 419-3834, or by e-mail at
joon@khanglaw.com.
This press release may constitute Attorney Advertising in some
jurisdictions.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151029006901/en/
KHANG & KHANG LLPJoon M. Khang, Esq.Telephone:
949-419-3834Facsimile: 949-225-4474joon@khanglaw.com
Heartware International, Inc. (MM) (NASDAQ:HTWR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Heartware International, Inc. (MM) (NASDAQ:HTWR)
Historical Stock Chart
From Apr 2023 to Apr 2024